The following represents disclosure information provided by authors of this abstract. The Genitourinary Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Validation of a genomic classifier for predicting biochemical failure following postoperative radiation therapy in high-risk prostate cancer.
Robert Benjamin Den
Research Funding - GenomeDx Biosciences
Felix Yi-Chung Feng
Consultant or Advisory Role - GenomeDx Biosciences (U)
Research Funding - GenomeDx Biosciences
Timothy Norman Showalter
Consultant or Advisory Role - GenomeDx Biosciences
Research Funding - GenomeDx Biosciences
Mark Vikas Mishra
No relevant relationships to disclose
Edouard John Trabulsi
No relevant relationships to disclose
Costas D. Lallas
No relevant relationships to disclose
Leonard G. Gomella
No relevant relationships to disclose
Ruth C. Birbe
No relevant relationships to disclose
Peter McCue
No relevant relationships to disclose
Mercedeh Ghadessi
Employment or Leadership Position - GenomeDx Biosciences
Stock Ownership - GenomeDx Biosciences
Karen E. Knudsen
No relevant relationships to disclose
Adam Dicker
No relevant relationships to disclose